Prognostic significance of a combination of novel biomarkers in the long-term stratification of adverse outcomes in patients with ST-segment elevation myocardial infarction

A multi-marker approach for assessing the prognosis of patients with ST-segment elevation myocardial infarction (STEMI) is a promising strategy.Aim. To assess the potential prognostic power of soluble growth stimulation gene-2 (sST2), pentraxin 3 (PTX3), and N-terminal pro-brain natriuretic peptide...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	D. F. Gareeva, A. F. Khamitova, I. A. Lakman, R. P. Ronzhin, R. Kh. Zulkarneev, M. R. Plotnikova, E. L. Tulbaev, L. J. Motloch, N. Sh. Zagidullin
Format:	Artigo
Sprog:	Russo
Udgivet:	«FIRMA «SILICEA» LLC 2020-12-01
Serier:	Российский кардиологический журнал
Fag:	stemi cardiovascular events cardiovascular death risk stratification sst2 nt-probnp pentraxin-3
Online adgang:	https://russjcardiol.elpub.ru/jour/article/view/3948
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!